Loading insider details...
Beta
Latest Form 4 (Jun 16, 2026): Grant/Award of 31,000 TARA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Protara Therapeutics, Inc. (TARA) | Grant/Award | 31,000 | n/a |
| Oct 7, 2025 | Prelude Therapeutics Inc (PRLD) | Exercise/Conversion | 9,375 | n/a |
| Jul 8, 2025 | Prelude Therapeutics Inc (PRLD) | Exercise/Conversion | 9,375 | n/a |
| Jun 13, 2025 | Protara Therapeutics, Inc. (TARA) | Grant/Award | 24,000 | n/a |
| Apr 7, 2025 | Prelude Therapeutics Inc (PRLD) | Exercise/Conversion | 9,375 | n/a |
| Feb 5, 2025 | Prelude Therapeutics Inc (PRLD) | Grant/Award | 200,000 | n/a |
| Jan 7, 2025 | Prelude Therapeutics Inc (PRLD) | Exercise/Conversion | 9,375 | n/a |
| Oct 7, 2024 | Prelude Therapeutics Inc (PRLD) | Exercise/Conversion | 9,375 | n/a |
| Jul 8, 2024 | Prelude Therapeutics Inc (PRLD) | Exercise/Conversion | 9,375 | n/a |
| Jun 10, 2024 | Protara Therapeutics, Inc. (TARA) | Grant/Award | 10,000 | n/a |